Positive Data For Drug That Treats Treatment-Refractory Chronic Cough
COPD, News
A new publication from Afferent Pharmaceuticals’ Phase 2 clinical trial results entitled “P2X3 Receptor Antagonist (AF-219) in Refractory Chronic Cough: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study” was published in ... Read more